Skip to main content
. 2022 Aug 11;12:13695. doi: 10.1038/s41598-022-17804-w

Table 1.

The table presents baseline characteristics of the cohort (N = 666).

Characteristic n/N (%)
Gender
Male 465/666 (70)
Female 201/666 (30)
Age group
< 30 years 79/666 (11)
30–39 years 188/666 (28)
40–49 years 205/666 (31)
50–59 years 155/666 (23)
≥ 60 years 39/666 (6)
Education level
Not completed primary school 36/666 (5)
Primary school (9 years) 300/666 (45)
High school (12 years) 267/666 (40)
≤ 3 years higher education 52/666 (8)
> 3 years higher education 11/666 (2)
Source of income
Paid labor 50/666 (8)
Social benefits1 616/666 (92)
Housing condition2
Unstable 79/666 (12)
Stable 587/666 (88)
HCV infection3 310/595 (52)
Injecting substances4 321/609 (53)
Opioid agonist therapy 594/666 (89)
Buprenorphine 356/594 (60)
Methadone 229/594 (39)
Other opioids 9/594 (2)
Weekly substance use5
Alcohol 151/607 (25)
Cannabis 304/607 (50)
Stimulants6 159/607 (26)
Benzodiazepines 230/607 (38)
Non-OAT opioids 83/607 (14)
No weekly substance use 142/607 (23)
Weekly tobacco use7 564/607 (85)

1Social benefits include disability, disease and unemployment benefits and work assessment allowance.

2Stable housing included living in owned or rented housing or at an institution, unstable housing included homelessness, living at temporary camping sites or with friends or family.

3Hepatitis C virus infection, defined as non-zero values on a quantitative HCV-RNA assay at baseline.

4Self-reported injection of any substance during the 6 months prior to the first health assessment.

5Self-reported substance use on a minimum weekly basis during the 12 months prior to the first health assessment.

6Amphetamine, methamphetamine or cocaine, 7Self-reported tobacco use (smoking or snuff) on a minimum weekly basis during the 12 months prior to the first health assessment.